Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Filgotinib to silence autoreactive B cells in rheumatoid arthritis
2021-006007-15Phase 4Terminated
- Sponsor
- Leiden University Medical Center
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of filgotinib in rheumatoid arthritis (RA) (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Change in frequency of ACPA-expressing B cells secreting ACPA-IgG. Started Dec 2021; status: terminated.
02
Drugs
filgotinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2021-006007-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-006007-15.